Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Cross-sectional, Multi-center Study to Establish The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire (GerdQ)

NCT00901004 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00901004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00901004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Cross-sectional, Multi-center Study to Establish The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire (GerdQ)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
September 30, 2009
Enrollment
1,550 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease